1 of 3 listed pharmas making net profit/sales ratio even less than 1%

Published: 2018-03-27 16:09:38

Updated: 2018-03-27 16:09:38

The polarization in profitability is reportedly getting serious as one of 3 listed pharmaceutical companies have a net profit ratio to sales less than 1%.

Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports that KOSPI and KOSDAQ listed pharmaceutical companies turned in, and the analysis showed that their net profit/sales ratio was 6.1% on average for the past 3 years. <holding and biote...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.